Back to today’s briefing

Story perspectives

UK Approves Needle-Free Adrenaline Spray for Anaphylaxis

7/25/2025

35 5

Summary

Story summary

The UK has greenlit EURneffy, a revolutionary needle-free adrenaline nasal spray designed to combat anaphylaxis in adults and children over 30kg. This innovative spray, which administers a 2mg dose even through a blocked nose, offers a vital alternative to traditional auto-injectors. Patients are advised to carry two sprays, with availability anticipated later this year.

1 of 1

Story summary

The UK has greenlit EURneffy, a revolutionary needle-free adrenaline nasal spray designed to combat anaphylaxis in adults and children over 30kg. This innovative spray, which administers a 2mg dose even through a blocked nose, offers a vital alternative to traditional auto-injectors. Patients are advised to carry two sprays, with availability anticipated later this year.